MedPath

Laparoscopic Cholecystectomy for Acute Cholecystitis After 72 Hours of Symptoms

Not Applicable
Terminated
Conditions
Acute Cholecystitis
Cholecystectomy
Registration Number
NCT01548339
Lead Sponsor
University of Lausanne Hospitals
Brief Summary

The purpose of this study is to compare the clinical outcomes of early versus delayed laparoscopic cholecystectomies for acute cholecystitis with more than 72 hours of symptoms.

Detailed Description

In acute biliary cholecystitis, there was a dogma that patients should be operated within 72 hours of evolution. However, retrospective studies suggested that laparoscopic cholecystectomy even after 72 hours was safe. Moreover, some randomized controlled-trials did not found any differences in term of complications between early and delayed cholecystectomy, however none of these studies did separate patients according to the onset of symptoms. The aim of our present study was to compare the clinical outcomes of immediate versus delayed cholecystectomies for acute cholecystitis with more than 72 hours of symptoms.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
86
Inclusion Criteria
  • proven echographic cholecystitis
Exclusion Criteria
  • pregnancy
  • immunosuppression
  • severe sepsis
  • perforated cholecystitis
  • peritonitis
  • cholangitis
  • acute pancreatitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Participants With Adverse Event ("Global Morbidity").30 postoperative days

any adverse event occurring from time of diagnosis until the 30th postoperative day

Secondary Outcome Measures
NameTimeMethod
Postoperative Complications30 postoperative days

postoperative complications graded according to Clavien classification

Length of Stay30 postoperative days

total in hospital stay

Trial Locations

Locations (1)

University of Lausanne Hospitals

🇨🇭

Lausanne, Vaud, Switzerland

University of Lausanne Hospitals
🇨🇭Lausanne, Vaud, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.